About 2.5K results
Open links in new tab
US FDA approves J&J’s Rybrevant plus standard of care as first …
New Novartis data in relapsing MS reinforce benefits of Kesimpta …
Astellas Pharma announces US FDA listing of DIGITIVA for the …
Roche announces phase III CENTERSTONE study of Xofluza …
US FDA approves Roche’s Ocrevus Zunovo to treat relapsing …
US FDA grants Emergency Use Authorization to Novavax 2024 …
JB Pharma accelerates global expansion and diversifies into …
Pfizer, BioNTech receive US FDA approval & authorization for …
News - Pharmabiz.com
Boehringer Ingelheim’s Cyltezo to treat multiple chronic …